Caricamento...
Personalized nanomedicine for CNS diseases
Central nervous system (CNS) diseases are rapidly increasing globally. Currently used therapeutic agents to treat CNS diseases exhibit significant efficacy. However, the inability of these drugs to cross the blood–brain barrier (BBB) and invasiveness of the technologies to achieve localized drug del...
Salvato in:
| Pubblicato in: | Drug Discov Today |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6897362/ https://ncbi.nlm.nih.gov/pubmed/29155026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2017.11.010 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|